- FTC to Hold Public Workshop in Washington, D.C. on March 7, 2018 to Examine the Contact Lens Marketplace and Proposed Changes to the Commission’s Contact Lens Rule ( )
- FTC Approves Final Order Preserving Competition in the U.S. Markets for Two Types of Medical Testing Devices ( )
- FTC Staff Opinion: Crouse Health Hospital’s Proposed Rx Program Is Exempt from Robinson-Patman Act ( )
- FTC to Hold Workshop on Examining Competition Issues Related to Prescription Drug Markets ( )
- FTC Staff Comment Supports VA Telehealth Rule that Will Increase Access to Care, Promote Competition, and Benefit Veterans ( )
- FTC Staff Seeks Empirical Research and Public Comments Regarding Impact of Certificates of Public Advantage ( )
- FTC Staff Supports Certificate of Need Application for Lee County, Georgia ( )
- FTC Announces Agenda for November 8 Workshop on Examining Competition Issues Related to Prescription Drug Markets ( )
- FTC Seeks Public Comment on Fresenius Medical Care AG’s Application for Approval of Proposed Plan to Establish New Outpatient Hemodialysis Clinic ( )
- FTC to Conduct Workshop on November 8, Examining Competition Issues Related to Prescription Drug Markets ( )
- FTC Requires Abbott Laboratories to Divest Two Types of Point-Of-Care Medical Testing Devices as Condition of Acquiring Alere Inc. ( )
- FTC Requires Divestiture of 5 Medical Device Product Lines as Condition of Integra Acquiring Johnson & Johnson’s Codman Neuro Division ( )
- FTC Final Order with Baxter International and Claris Lifesciences Preserves U.S. Competition for the Injectable Drugs Intravenous Fluconazole and Intravenous Milrinone ( )
- FTC to Join CDC Twitter Chat on Healthy Contact Lens Wear and Care ( )
- FTC Staff Provides Additional Comment and Testimony in Tennessee Opposing Mountain States’ and Wellmont’s Certificate of Public Advantage Application ( )
- FTC Approves Sublicense for Synacthen Depot Submitted by Mallinckrodt ARD Inc. ( )
- FTC and State Attorney General Challenge Physician Group Acquisition in North Dakota ( )
- Federal Trade Commission Closes Investigation of Texas Medical Board After Texas Passes Law Expanding Telemedicine and Telehealth Services ( )
- FTC Obtains Court Approval of Divestiture of Saltzer Medical Group by Idaho-based St. Luke’s Health System ( )
- FTC Workshop on April 18 Explores Hearing Health and Technology ( )
- FTC Announces Final Agenda on Hearing Health and Technology Workshop ( )
- FTC and DOJ Support Reform of Alaska Laws That Limit Competition in the Health Care Sector ( )
- FTC Announces Preliminary Agenda for Hearing Health and Technology Workshop ( )
- FTC Requires Kidney Dialysis Chain DaVita, Inc. to Divest Assets as a Condition of Acquiring Competitor Renal Ventures Management LLC ( )
- FTC Releases 2016 Annual Highlights ( )
- After Two Chicago-area Hospital Systems Abandon Proposed Merger, FTC Dismisses Case from Administrative Trial Process ( )
- FTC Staff Comment on Ohio State Legislative Effort to Enhance Access to Dental Care ( )
- Statement from Federal Trade Commission’s Bureau of Competition Acting Director on District Court Ruling to Enjoin Advocate/NorthShore Hospital Merger ( )
- FTC Approves Final Order Preserving Competition in U.S. Markets for Medical Devices Used in Cardiac and Vascular Catheterization ( )
- FTC Approves Final Order with Parent Company of Bausch + Lomb ( )
El .gov significa que es oficial.
Los sitios web del gobierno federal siempre usan un dominio .gov o .mil. Antes de compartir información confidencial en línea, asegúrese de estar en un sitio .gov o .mil.
Este sitio es seguro.
El https:// medios todos los datos transmitidos son cifrados - en otras palabras, cualquier información o el historial de navegación que proporcione se transmite de forma segura.